KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to 0.07%.

  • Bristol Myers Squibb's Return on Invested Capital rose 2200.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.35% for FY2024, which is 3300.0% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Return on Invested Capital of 0.07% as of Q3 2025, which was up 2200.0% from 0.09% recorded in Q2 2025.
  • Bristol Myers Squibb's Return on Invested Capital's 5-year high stood at 0.02% during Q1 2023, with a 5-year trough of 0.36% in Q4 2024.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.07% (2025), whereas its average is 0.12%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first skyrocketed by 2400bps in 2021, then plummeted by -3300bps in 2024.
  • Bristol Myers Squibb's Return on Invested Capital (Quarter) stood at 0.02% in 2021, then crashed by -37bps to 0.03% in 2022, then decreased by -24bps to 0.03% in 2023, then crashed by -1031bps to 0.36% in 2024, then skyrocketed by 79bps to 0.07% in 2025.
  • Its Return on Invested Capital stands at 0.07% for Q3 2025, versus 0.09% for Q2 2025 and 0.11% for Q1 2025.